anmelden
SMI
14.231,96
PKT
+114,21
PKT
+0,81
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.22 | Holcim Hold | Deutsche Bank AG | |
| 28.04.22 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 27.04.22 | Richemont Buy | HSBC | |
| 27.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.04.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 27.04.22 | UBS Outperform | Credit Suisse Group | |
| 27.04.22 | Novartis Neutral | Credit Suisse Group | |
| 27.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.22 | UBS Buy | Deutsche Bank AG | |
| 27.04.22 | UBS Neutral | Goldman Sachs Group Inc. | |
| 27.04.22 | Novartis Neutral | UBS AG | |
| 27.04.22 | Novartis Sell | Deutsche Bank AG | |
| 27.04.22 | UBS Sector Perform | RBC Capital Markets | |
| 27.04.22 | UBS Outperform | RBC Capital Markets | |
| 27.04.22 | UBS Hold | Jefferies & Company Inc. | |
| 27.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 27.04.22 | UBS Underweight | Barclays Capital | |
| 27.04.22 | UBS Equal Weight | Barclays Capital | |
| 26.04.22 | Novartis Neutral | UBS AG | |
| 26.04.22 | Roche Neutral | Credit Suisse Group | |
| 26.04.22 | Roche Buy | Deutsche Bank AG | |
| 26.04.22 | Roche Overweight | Barclays Capital | |
| 26.04.22 | Novartis Buy | Jefferies & Company Inc. | |
| 26.04.22 | UBS Buy | Jefferies & Company Inc. | |
| 26.04.22 | UBS Outperform | RBC Capital Markets | |
| 26.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.04.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 25.04.22 | Roche Outperform | Bernstein Research | |
| 25.04.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 25.04.22 | Holcim Buy | Deutsche Bank AG | |
| 25.04.22 | Swiss Re Sell | UBS AG | |
| 25.04.22 | Roche Sell | UBS AG | |
| 25.04.22 | Holcim Buy | UBS AG | |
| 25.04.22 | UBS Outperform | Credit Suisse Group | |
| 25.04.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 25.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 25.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.04.22 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.04.22 | Holcim Outperform | Credit Suisse Group |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.